Joerg Reinhardt

Cofounder, Novartis

Search every verified Joerg Reinhardt interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Joerg Reinhardt, cofounder at Novartis, spoke at the Novartis Lecture in Basel in November 2019, where he introduced the event and its speakers, professors Botond Roska and Hendrik Scholl, co-directors of the Institute of Molecular and Clinical Ophthalmology Basel (IOB). He noted that Novartis is a co-founding member of the institute and highlighted the collaboration between clinical and preclinical research as a key factor in advancing treatments for blindness and impaired vision. He also commented on the low level of medical innovation in ophthalmology over many years, citing myopia as an example of a condition affecting a growing number of people, particularly adolescents in Asia, with causes and treatment options still not fully understood. Reinhardt also emphasized the importance of cross-industry and cross-field collaboration for scientific breakthroughs, stating that Novartis engages in hundreds of research partnerships worldwide, including with data and digital leaders such as Microsoft. He expressed confidence that new medications in ophthalmology would emerge in the coming years, based on the work of researchers like Roska and Scholl.